FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3102163663> ?p ?o ?g. }

• W3102163663 endingPage "180" @default.
• W3102163663 startingPage "172" @default.
• W3102163663 abstract "The safety and efficacy of stereotactic body radiotherapy (SBRT) in localised prostate cancer are now established through phase III randomised trials. Its utility in node-positive prostate cancer is restricted due to a lack of controlled studies specifically addressing this subgroup. Herein we report the safety and efficacy of SBRT in this subgroup.In total, 60 patients treated with SBRT to prostate and pelvis were analysed. All patients received neoadjuvant androgen deprivation therapy for at least 6 months and long-term adjuvant hormonal therapy (70% medical and 30% surgical). All patients were treated with daily image-guided rotational intensity-modulated radiotherapy. The dose delivered to the prostate and gross node was 35-37.5 Gy and 25 Gy in five fractions to the elective pelvic nodal region on alternate days. Acute and late toxicities were graded as per Radiation Therapy Oncology Group common toxicity criteria.Forty-one (68%) patients had a Gleason score ≥8. The median prostate-specific antigen level at diagnosis was 39 ng/ml. Twenty (33%) patients had common iliac nodal uptake on initial prostate-specific membrane antigen positron emission tomography-computed tomography. After the median follow-up of 30 months, no acute or late Radiation Therapy Oncology Group grade ≥3 gastrointestinal toxicity was noted. Acute grade 2 genitourinary and gastrointestinal toxicities were 8.3% and 11.7%, respectively. Late grade 2 genitourinary and gastrointestinal toxicities were 3.3% and 8.3%, respectively. Late grade 3 genitourinary toxicity was seen in two (3.3%) patients. Three-year overall survival and biochemical failure-free survival was 89% and 77%, respectively.SBRT to the prostate and pelvis is safe and efficacious in node-positive prostate cancer even with common iliac nodal involvement (stage M1a)." @default.
• W3102163663 created "2020-11-23" @default.
• W3102163663 creator A5000334554 @default.
• W3102163663 creator A5021007452 @default.
• W3102163663 creator A5029884245 @default.
• W3102163663 creator A5031034758 @default.
• W3102163663 creator A5032924269 @default.
• W3102163663 creator A5033426733 @default.
• W3102163663 creator A5043528824 @default.
• W3102163663 creator A5049692975 @default.
• W3102163663 creator A5089418770 @default.
• W3102163663 date "2021-03-01" @default.
• W3102163663 modified "2023-10-01" @default.
• W3102163663 title "Safety and Efficacy of Ultra-hypofractionation in Node-positive Prostate Cancer" @default.
• W3102163663 cites W1965408806 @default.
• W3102163663 cites W2021220421 @default.
• W3102163663 cites W2043945205 @default.
• W3102163663 cites W2054326607 @default.
• W3102163663 cites W2074421032 @default.
• W3102163663 cites W2092920342 @default.
• W3102163663 cites W2093867637 @default.
• W3102163663 cites W2116340214 @default.
• W3102163663 cites W2126706478 @default.
• W3102163663 cites W2127900847 @default.
• W3102163663 cites W2142629844 @default.
• W3102163663 cites W2161462871 @default.
• W3102163663 cites W2176970460 @default.
• W3102163663 cites W2179945673 @default.
• W3102163663 cites W2271651445 @default.
• W3102163663 cites W2313148216 @default.
• W3102163663 cites W2511949746 @default.
• W3102163663 cites W2550605096 @default.
• W3102163663 cites W2573152477 @default.
• W3102163663 cites W2673309218 @default.
• W3102163663 cites W2732019947 @default.
• W3102163663 cites W2799764975 @default.
• W3102163663 cites W2811472135 @default.
• W3102163663 cites W2887702674 @default.
• W3102163663 cites W2897193214 @default.
• W3102163663 cites W2912635292 @default.
• W3102163663 cites W2915045195 @default.
• W3102163663 cites W2952903287 @default.
• W3102163663 cites W2990822673 @default.
• W3102163663 cites W4242791450 @default.
• W3102163663 doi "https://doi.org/10.1016/j.clon.2020.10.019" @default.
• W3102163663 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33214044" @default.
• W3102163663 hasPublicationYear "2021" @default.
• W3102163663 type Work @default.
• W3102163663 sameAs 3102163663 @default.
• W3102163663 citedByCount "6" @default.
• W3102163663 countsByYear W31021636632021 @default.
• W3102163663 countsByYear W31021636632022 @default.
• W3102163663 countsByYear W31021636632023 @default.
• W3102163663 crossrefType "journal-article" @default.
• W3102163663 hasAuthorship W3102163663A5000334554 @default.
• W3102163663 hasAuthorship W3102163663A5021007452 @default.
• W3102163663 hasAuthorship W3102163663A5029884245 @default.
• W3102163663 hasAuthorship W3102163663A5031034758 @default.
• W3102163663 hasAuthorship W3102163663A5032924269 @default.
• W3102163663 hasAuthorship W3102163663A5033426733 @default.
• W3102163663 hasAuthorship W3102163663A5043528824 @default.
• W3102163663 hasAuthorship W3102163663A5049692975 @default.
• W3102163663 hasAuthorship W3102163663A5089418770 @default.
• W3102163663 hasBestOaLocation W31021636631 @default.
• W3102163663 hasConcept C121608353 @default.
• W3102163663 hasConcept C126322002 @default.
• W3102163663 hasConcept C126838900 @default.
• W3102163663 hasConcept C126894567 @default.
• W3102163663 hasConcept C133507102 @default.
• W3102163663 hasConcept C143998085 @default.
• W3102163663 hasConcept C2776235491 @default.
• W3102163663 hasConcept C2777899217 @default.
• W3102163663 hasConcept C2778311097 @default.
• W3102163663 hasConcept C2780192828 @default.
• W3102163663 hasConcept C2781406297 @default.
• W3102163663 hasConcept C509974204 @default.
• W3102163663 hasConcept C71924100 @default.
• W3102163663 hasConceptScore W3102163663C121608353 @default.
• W3102163663 hasConceptScore W3102163663C126322002 @default.
• W3102163663 hasConceptScore W3102163663C126838900 @default.
• W3102163663 hasConceptScore W3102163663C126894567 @default.
• W3102163663 hasConceptScore W3102163663C133507102 @default.
• W3102163663 hasConceptScore W3102163663C143998085 @default.
• W3102163663 hasConceptScore W3102163663C2776235491 @default.
• W3102163663 hasConceptScore W3102163663C2777899217 @default.
• W3102163663 hasConceptScore W3102163663C2778311097 @default.
• W3102163663 hasConceptScore W3102163663C2780192828 @default.
• W3102163663 hasConceptScore W3102163663C2781406297 @default.
• W3102163663 hasConceptScore W3102163663C509974204 @default.
• W3102163663 hasConceptScore W3102163663C71924100 @default.
• W3102163663 hasIssue "3" @default.
• W3102163663 hasLocation W31021636631 @default.
• W3102163663 hasLocation W31021636632 @default.
• W3102163663 hasOpenAccess W3102163663 @default.
• W3102163663 hasPrimaryLocation W31021636631 @default.
• W3102163663 hasRelatedWork W2033603622 @default.
• W3102163663 hasRelatedWork W2040474332 @default.
• W3102163663 hasRelatedWork W2074491453 @default.

• next